Massive Bio is a dynamic health-tech startup founded in 2015, focused on revolutionizing access to clinical trials for cancer patients, irrespective of their geographical location or financial circumstances. The company has developed a proprietary patient recruitment and enrollment solution that addresses the challenges faced in traditional oncology clinical trial enrollment processes. With a passionate team dedicated to making a difference, Massive Bio aims to expand its network and enhance provider engagement, ensuring that every cancer patient has the opportunity to participate in clinical trials.